http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 30 Sep 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Strategic+Education%2C+Inc.+Schedules+Third+Quarter+2026+Results+Conference+Call/27128634.html <p> HERNDON, Va.--(BUSINESS WIRE)-- Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced that it will host a conference call to discuss its third quarter results on Thursday, November 5, 2026 at 10:00 a.m. ET. A news release outlining the results will be issued before the market opens the same day. </p><p> This call will be available via webcast. To access the live webcast of the conference call on November 5, please go to <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.strategiceducation.com&amp;esheet=54613578&amp;newsitemid=20260930416974&amp;lan=en-US&amp;anchor=www.strategiceducation.com&amp;index=1&amp;md5=877786573d20960c101e8a3ce2afef6f" shape="rect">www.strategiceducation.com</a> in the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.strategiceducation.com%2Finvestor-relations%2Foverview%2Fdefault.aspx&amp;esheet=54613578&amp;newsitemid=20260930416974&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=2&amp;md5=e0f853004387a2dda3821d4be953c886" shape="rect">Investor Relations</a> section 15 minutes prior to the start time of the call to register. http://www.streetinsider.com/Press+Releases/Strategic+Education%2C+Inc.+Schedules+Third+Quarter+2026+Results+Conference+Call/27128634.html Wed, 30 Sep 2026 16:05:00 -0400 STRA http://www.streetinsider.com/Business+Wire/Strategic+Education%2C+Inc.+Schedules+Third+Quarter+2026+Results+Conference+Call/27128634.html <p> HERNDON, Va.--(BUSINESS WIRE)-- Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced that it will host a conference call to discuss its third quarter results on Thursday, November 5, 2026 at 10:00 a.m. ET. A news release outlining the results will be issued before the market opens the same day. </p><p> This call will be available via webcast. To access the live webcast of the conference call on November 5, please go to <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.strategiceducation.com&amp;esheet=54613578&amp;newsitemid=20260930416974&amp;lan=en-US&amp;anchor=www.strategiceducation.com&amp;index=1&amp;md5=877786573d20960c101e8a3ce2afef6f" shape="rect">www.strategiceducation.com</a> in the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.strategiceducation.com%2Finvestor-relations%2Foverview%2Fdefault.aspx&amp;esheet=54613578&amp;newsitemid=20260930416974&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=2&amp;md5=e0f853004387a2dda3821d4be953c886" shape="rect">Investor Relations</a> section 15 minutes prior to the start time of the call to register. http://www.streetinsider.com/Business+Wire/Strategic+Education%2C+Inc.+Schedules+Third+Quarter+2026+Results+Conference+Call/27128634.html Wed, 30 Sep 2026 16:05:00 -0400 STRA http://www.streetinsider.com/Press+Releases/Harris+Poll%3A+70%25+of+Gen+Z+Healthcare+Workers+Look+to+Leave+as+U.S.+Faces+Critical+Healthcare+Workforce+Shortage%2C+Commissioned+by+Workforce+Edge/27067310.html <p class="bwalignc"> <i>Survey reveals expectations of younger employees; declining interest in AI among employers</i> </p> <p> HERNDON, Va.--(BUSINESS WIRE)-- One year after the initial survey, the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fworkforceedge.com%2Fhealthcare-workforce-barometer%3Futm_id%3Dsei238%26utm_source%3Dpartner%26utm_medium%3Dweb%26utm_campaign%3Dhealthc&amp;esheet=54604967&amp;newsitemid=20260916296354&amp;lan=en-US&amp;anchor=2026+Healthcare+Workforce+Barometer&amp;index=1&amp;md5=6f9d8f23c55a84ad15024133ae7e5b7c" shape="rect">2026 Healthcare Workforce Barometer</a> conducted by The Harris Poll finds that more than half of the healthcare workforce (59%) is still looking to leave with 70% of Gen Z healthcare workers saying they will look for a new role in the next year. These findings come as the U.S. is projected to face a shortage of nearly 500,000 critical healthcare workers by 2038 <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fdata.hrsa.gov%2Ftopics%2Fhealth-workforce%2Fnchwa%2Fworkforce-projections&amp;esheet=54604967&amp;newsitemid=20260916296354&amp;lan=en-US&amp;anchor=%28HRSA%2C+2025%29&amp;index=2&amp;md5=929e6dc6caa3720d3aaf751766c84e9a" shape="rect">(HRSA, 2025)</a>. </p><p> Strategic Education, Inc. http://www.streetinsider.com/Press+Releases/Harris+Poll%3A+70%25+of+Gen+Z+Healthcare+Workers+Look+to+Leave+as+U.S.+Faces+Critical+Healthcare+Workforce+Shortage%2C+Commissioned+by+Workforce+Edge/27067310.html Wed, 16 Sep 2026 07:02:00 -0400 STRA http://www.streetinsider.com/Business+Wire/Harris+Poll%3A+70%25+of+Gen+Z+Healthcare+Workers+Look+to+Leave+as+U.S.+Faces+Critical+Healthcare+Workforce+Shortage%2C+Commissioned+by+Workforce+Edge/27067310.html <p class="bwalignc"> <i>Survey reveals expectations of younger employees; declining interest in AI among employers</i> </p> <p> HERNDON, Va.--(BUSINESS WIRE)-- One year after the initial survey, the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fworkforceedge.com%2Fhealthcare-workforce-barometer%3Futm_id%3Dsei238%26utm_source%3Dpartner%26utm_medium%3Dweb%26utm_campaign%3Dhealthc&amp;esheet=54604967&amp;newsitemid=20260916296354&amp;lan=en-US&amp;anchor=2026+Healthcare+Workforce+Barometer&amp;index=1&amp;md5=6f9d8f23c55a84ad15024133ae7e5b7c" shape="rect">2026 Healthcare Workforce Barometer</a> conducted by The Harris Poll finds that more than half of the healthcare workforce (59%) is still looking to leave with 70% of Gen Z healthcare workers saying they will look for a new role in the next year. These findings come as the U.S. is projected to face a shortage of nearly 500,000 critical healthcare workers by 2038 <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fdata.hrsa.gov%2Ftopics%2Fhealth-workforce%2Fnchwa%2Fworkforce-projections&amp;esheet=54604967&amp;newsitemid=20260916296354&amp;lan=en-US&amp;anchor=%28HRSA%2C+2025%29&amp;index=2&amp;md5=929e6dc6caa3720d3aaf751766c84e9a" shape="rect">(HRSA, 2025)</a>. </p><p> Strategic Education, Inc. http://www.streetinsider.com/Business+Wire/Harris+Poll%3A+70%25+of+Gen+Z+Healthcare+Workers+Look+to+Leave+as+U.S.+Faces+Critical+Healthcare+Workforce+Shortage%2C+Commissioned+by+Workforce+Edge/27067310.html Wed, 16 Sep 2026 07:02:00 -0400 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html <p>Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.</p> <p>Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.</p> <p>Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in http://www.streetinsider.com/Board+Changes/Capella+University+names+oncologist+Dr.+Saro+Sarkisian+to+board/26952647.html Thu, 20 Aug 2026 07:01:11 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Business+Wire/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html <p> MINNEAPOLIS--(BUSINESS WIRE)-- Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees. A board-certified medical oncologist and hematologist, Dr. Sarkisian brings deep expertise he developed through his years treating patients, leading care teams and advising on new oncology therapies. </p><p> Dr. Sarkisian currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and also practices at the James M. Stockman Cancer Institute in Frederick, Maryland, where he has served as a lead oncologist in high-volume clinical settings and as local principal investigator on numerous national and international clinical trials. As http://www.streetinsider.com/Press+Releases/Capella+University+Announces+Appointment+of+Oncology+Leader+Dr.+Saro+Sarkisian+to+Board+of+Trustees/26952644.html Thu, 20 Aug 2026 07:01:00 -0400 A.17409901 A.32437804 A.35954321 A.41389538 A.50216726 O.00162576 O.01913171 O.01982880 O.20737027 O.21612337 O.41713299 STRA